{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:33:53Z","timestamp":1764401633337},"reference-count":22,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T00:00:00Z","timestamp":1402876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.vaccine.2014.06.036","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T05:18:44Z","timestamp":1403068724000},"page":"4751-4757","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka"],"prefix":"10.1016","volume":"32","author":[{"given":"Pushpa Ranjan","family":"Wijesinghe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R. Nihal","family":"Abeysinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour","family":"Yaich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.06.036_bib0005","series-title":"Vaccines","first-page":"919","article-title":"Japanese encephalitis","author":"Halstead","year":"2004"},{"issue":"34","key":"10.1016\/j.vaccine.2014.06.036_bib0010","first-page":"357","article-title":"Japanese encephalitis: status of surveillance and immunization in Asia and the Western Pacific, 2012","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"34\u201335","key":"10.1016\/j.vaccine.2014.06.036_bib0015","first-page":"331","article-title":"Japanese encephalitis vaccines","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0020","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines. WHO, Geneva, 2\u20133 September 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0025","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","article-title":"Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated encephalitis SA 14-14-2 vaccine in Philippine infants","volume":"26","author":"Gatchalian","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4038\/cmj.v45i3.8103","article-title":"Seroconversion rate following measles vaccination","volume":"45","author":"Gunawardena","year":"2000","journal-title":"Ceylon Med J"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0035","unstructured":"ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6(R1). Current Step 4 version dated 10 June 1996 (including the Post Step 4 corrections). Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf [accessed 27.04.14]."},{"key":"10.1016\/j.vaccine.2014.06.036_bib0040","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2013 global summary. Available at apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=LKA [accessed 27.04.14]."},{"key":"10.1016\/j.vaccine.2014.06.036_bib0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0140-6736(90)92501-8","article-title":"Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine","volume":"336","author":"Whittle","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0050","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1016\/j.vaccine.2013.08.044","article-title":"Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or 9 and 18 months of age: a serological study within a randomized trial of different measles vaccines","volume":"31","author":"Martins","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.06.036_bib0055","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1093\/infdis\/jir135","article-title":"Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi","volume":"204","author":"Fowlkes","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.vaccine.2013.11.002","article-title":"Corrigendum to \u201cComparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants\u201d [Vaccine 26 (2008) 2234\u20132241]","volume":"32","author":"Victor","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0065","series-title":"Presented at: 8th Vaccine & ISV Congress","article-title":"Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a Good Manufacturing Practices facility and non-inferiority with respect to an earlier product","author":"Zaman","year":"2013"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.06.036_bib0070","first-page":"S195","article-title":"Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand","volume":"94","author":"Chotpitayasunondh","year":"2011","journal-title":"J Med Assoc Thai"},{"issue":"18","key":"10.1016\/j.vaccine.2014.06.036_bib0075","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0264-410X(99)00006-7","article-title":"Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants","volume":"17","author":"Sohn","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0080","unstructured":"World Health Organization. The immunological basis for immunization series module 7: measles, update 2009. Available at: http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241597555_eng.pdf?ua=1 [accessed 27.04.14]."},{"issue":"29","key":"10.1016\/j.vaccine.2014.06.036_bib0085","first-page":"301","article-title":"Report of the Global Advisory Committee on Vaccine Safety, 12\u201313 June 2013","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0090","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(96)91070-3","article-title":"Japanese encephalitis: a Chinese solution?","volume":"347","author":"Steinhoff","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0100","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)67567-8","article-title":"Effect of single dose of SA 14-14-2 vaccine 1 year after immunization in Nepalese children with Japanese encephalitis: a case\u2013control study","volume":"366","author":"Ohrr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0105","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.036_bib0110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4269\/ajtmh.12-0196","article-title":"Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal","volume":"88","author":"Upreti","year":"2013","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T08:57:29Z","timestamp":1538557049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14008251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":22,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0264410X14008251"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}